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Abstract
Introduction: Tuberculosis remains an infectious disease with a high prevalence worldwide and
represents a major public health issue. Although venous thromboembolism is a rare complication
of this disease, it may be a potentially life-threatening event.
Case series presentation: We report two cases of severe pulmonary tuberculosis associated
with venous thromboembolism. A 38 year-old caucasian male that had a thromboembolic event as
an unsual presentation form of tuberculosis and a 51 year-old caucasian male that developed deep
venous thrombosis later in the course of the disease.
Conclusion: An association between inflamation induced by tuberculosis and a hypercoagulable
state has been described. Therefore, the occurence of deep venous thrombosis or pulmonary
embolic episods, should be considered in patients with tuberculosis particulary during the first
weeks of treatment. The physician's awarness of these phenomena is important to an early
diagnostic suspicion and prompt treatment in order to prevent fatal outcomes.
Introduction
Tuberculosis (TB) is one of the most prevalent infectious
diseases in our country with an estimated incidence rate of
25.3 per 100.000 population in 2008 [1]. Worldwide, TB
is responsible for more than 1.5 million deaths every year
[1], with an estimated rate of 13.7 million prevalent cases
of TB in 2007 (206 per 100.000 population) [2]. There-
fore, despite recent progress, TB remains an important
global public health problem [2], fact that should draw
our attention to venous thromboembolism (VTE) as a
possible complication of this disease.
Although deep venous thrombosis (DVT) is considered a
rare event, it should be taken into consideration particu-
larly in those with severe pulmonary or disseminated
tuberculosis, as some authors correlate the risk of devel-
oping DVT increasing with the severity of the disease [3].
According to a retrospective analysis in a South African
Hospital in the mid 1980s, White et al. stated that DVT rate
was 3.4% within the first two weeks after initiation of
therapy [4]. Recently, Ambrosetti et al., performed a nation-
wide prospective study comprising a routine evaluation of
treatment outcomes in TB patients. This Italian group con-
cluded that the prevalence of VTE was 0.6% in the first
month of treatment, one third occurring in the first week.
Furthermore, all cases except one, occurred in hospital-
ized patients [5].
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a few days after the diagnosis [7] or late in the course of
the disease, even in patients on anti-tuberculosis treat-
ment (ATT) [8].
Like other infectious diseases, TB can cause thrombosis by
various mechanisms such as local invasion, venous com-
pression [6] or by producing a transitory hypercoagulable
state [9,10]. Recent studies have established a link
between haemostatic changes and this prothrombotic
phase, and have demonstrated that these can normalize
with an adequate ATT [10].
Because VTE can be fatal, it is crucial to suspect it to per-
form an early diagnosis and initiate prompt treatment [3].
For this reason, patients that respond poorly to ATT, who
have other predisposing factors and those in need of a
prolonged stay in hospital, should be carefully monitored
[10]. In some, prophylactic heparin should be prescribed
and the use of venous catheters avoided [3].
We report two cases of severe pulmonary tuberculosis
associated with VTE.
Case report 1
A 38 year-old caucasian male, heavy smoker (40 pack/
year), was presented to the emergency department (ED)
with a painful swelling of the left lower limb of 15 days
duration. He also complained of productive cough, ano-
rexia and weight loss within the past 6 months. He was
not on any medications and had no allergies. At that
moment, he was an unemployed construction worker and
a moderate alcohol consumer. General physical examina-
tion revealed a poorly built, malnourished man weighing
47 Kg. He was febrile (axilar temperature 38.3°C), taqui-
cardic (pulse 102 bpm) and normotensive. Pulse oximetry
(FiO2 21%) was 96% and chest auscultation revealed
bilateral rhonchi. Cardiovascular and abdominal exami-
nation was normal. His left leg was swollen and tender to
touch.
Arterial blood gas analysis (FiO2 = 21%) showed hypox-
emia (pO2 = 89 mmHg). Laboratory findings on admis-
sion revealed a normal WBC count (7.9 G/mm3), a low
hemoglobin level (11.3 g/dL), macrocytosis (MGV 106.2
fL), normal platelet count (397.000/mm3), hiponatremia
(131 mEq/L) and elevated CRP (5.20 mg/dl) and d-dimer
levels (5.51 ug/ml - normal < 0.5). Plasma fibrinogen
level was also high (455 mg/dl - normal range 200-400).
Chest X-ray demonstrated bilateral infiltrations and mul-
tiple cavitary lesions in both lungs (Figure 1). Deep
venous thrombosis was confirmed by leg ultrasound.
Chest CT angiography performed showed occlusion of
distal segment of left pulmonary artery and right basal
segmental branches, compatible with bilateral pulmonary
embolism. There were also findings consistent with severe
pulmonary tuberculosis (Figure 2A, B).
Mycobacterium tuberculosis (MT) infection was con-
firmed by culture on Lowenstein-Jensen agar and MT
organisms were found to be sensitive to all first-line anti-
tuberculosis drugs. Serologic testing for HIV, HBV and
HCV were negative.
Standard ATT was initiated adjusted to weight: isoniazid
(200 mg/day), rifampin (480 mg/day), pyrazinamid
(1200 mg/day) and ethambutol (800 mg/day). The
patient was treated with low-molecular-weight heparin
(60 mg twice daily) and 3 days later, warfarin (5 mg/day)
was started with a target International Normalized Ratio
(INR) of 2.0-3.0.
On ATT his general state improved and he responded well
to anticoagulation therapy. No adverse effects were seen.
Chest X-ray on admissionFigure 1
Chest X-ray on admission.
Chest CT angiography on admissionFigure 2
Chest CT angiography on admission. Multiple cavitary 
lesions in upper lobes and apical segments of lower lobes in 
communication with the bronquial tree (Figure 2A). Micron-
odules scattered in different pulmonary lobes with a "tree in 
bud" pattern. (bronquial disseminated tuberculosis). Hilar 
and paratracheal pericentimetric adenopathies were also 
identified (Figure 2B).
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follow-up at the Pneumology Diagnostic Centre. The
patient has now finished two months on ATT regimen
with isoniazid (200 mg/day) and rifampin (480 mg/day)
with a good clinical response.
Case 2
A 51 year-old male, ex-smoker, presented to the ED with
a 3-week history of anorexia, productive cough with yel-
low sputum and weight loss. He also complained of night
sweats and vomiting in the last 3 days. There was no prior
history of other diseases but he had contacted in the last
few months with a patient with TB. There was no history
of alcohol abuse or sexual risk behaviors.
Clinical examination, revealed a thin, ill-appearing-man,
weighing 40 kg. He was febrile (axilar temperature
38.4°C), hypotensive (BP 90/53 mmHg) and tachycardic
(pulse 118 bpm). His respiratory rate was normal with an
oxygen saturation of 98% (FiO2 = 21%). Examination of
chest and abdomen was unremarkable. No peripheral
edema was found.
Routine investigations revealed anemia (Hb 10.5 g/dl),
leucocytosis (WBC 13.8 G/L) and a high platelet count
(635.000/mm3). Other abnormal results included
hiponatremia (129 mEq/L), high CRP (18.09 mg/dL) and
fibrinogen levels (668 mg/dl). Arterial blood gas analysis
(FiO2 21%) showed: pH 7.47; pO2 92 mmHg; pCO2 33.8
mmHg; HCO3 24.3 mmol/L; oxygen saturation 98.5%.
Chest X-ray demonstrated a heterogeneous consolidation
of both lung fields, mainly in the upper 2/3, consistent
with tuberculosis (Figure 3A).
Sputum was found to contain acid-fast bacilli (> 36
bacilli/field) and MT subsequently cultured and found to
be susceptible to all first line drugs. Serologic tests for HIV,
HBV e HCV were negative.
ATT including isoniazid (250 mg/day), rifampicin (600
mg/day), pyrazinamid (1500 mg/day), ethambutol (1200
mg/day) and piridoxin (40 mg/day) was started. After two
weeks in hospital, patient presented favorable response
with improvement in constitutional symptoms and was
discharged to continue ATT at the Diagnostic Pneumology
Centre. He returned to the ED complaining of pain and
swelling in his left limb 13 days later. Ultrasound revealed
a femoropopliteal thrombosis. He was put on low-molec-
ular-weight heparin (60 mg twice daily) and warfarin (5
mg/day) on the same day. Since therapeutic INR level was
difficult to maintain with high doses (15 mg) of warfarin,
acenocumarol was initiated.
Chest CT showed multiple confluent cavitary lesions
mainly in the upper lobes, consolidation and micronod-
ules, consistent with extensive pulmonary tuberculosis. A
right hilar adenopathy (17 mm) and mediastinal aden-
opathies (some larger than 10 mm) were also observed.
Abdominal and pelvic CT was performed and revealed
homogeneous hepatomegaly and no focal parenchymal
lesions. Tumor makers were negative. Since his bacterio-
logical and radiological response (Figure 2B) to ATT was
slow, he had to complete an 18-month therapy regimen.
Discussion
Our cases show that VTE may complicate severe pulmo-
nary tuberculosis and that these events occur at presenta-
tion or later in the course of the disease. Robson et al.,
found 35 patients with pulmonary TB and DVT. In 33 of
them, DVT occurred 7 days after the diagnosis of TB, while
only in two, DVT was the presenting feature [11]. Other
reports also demonstrate that thrombotic phenomena in
patients with pulmonary TB occur in other sites. These
may include hepatic veins [8] and cerebral venous sinuses
[12], which reinforces the link between these conditions.
Actually, tuberculosis is a disease with a wide variety of
clinical presentations and recently, the association
between inflammation, haemostatic changes and a hyper-
coagulable state has been established [9,10]. Robson et al.
research study suggested that elevated plasma fibrinogen,
impaired fibrinolysis coupled with decreased levels of
antithrombin III and reactive thrombocytosis appeared to
favour the development of DVT in pulmonary TB [11].
Similar observations were made by Turken et al. in a case-
control study, regarding these haemostatic disturbances in
45 patients with active pulmonary TB. Moreover, it stated
that these changes improved with ATT within 4 weeks
[10]. On the other hand, there is also data supporting a
relationship between this prothrombotic phase and a
high frequency of antiphospholipid antibodies and pro-
tein S deficiency [3].
However, thrombosis can also result from venous com-
pression by lymph nodes in ganglionar forms of TB, as ret-
Chest X-ray on admission (A)Figure 3
Chest X-ray on admission (A). Chest X-ray 8 months 
later, showing exsudative lesions on both upper lobes (B).
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roperitoneal adenopathies may cause inferior vena cava
thrombosis in the absence of any haemostatic abnormal-
ities [6].
These haemostatic changes improve during the first
month of ATT [10] and for this reason, it should be imme-
diately started in addition to anticoagulant therapy. Fre-
quently, a higher dose of warfarin is necessary to achieve
therapeutic INR levels, because of rifampin effects on
cytochrome P450 [13]. Additionally, this drug may also
contribute to the hypercoagulable state by decreasing pro-
duction and increasing clearance of anticoagulant hepatic
proteins. Consequently, the initial phase of treatment
may result in a higher risk for development of DVT [9].
Conclusions
These clinical reports emphasize that patients with severe
pulmonary tuberculosis are at risk of developing throm-
boembolic events. Therefore, these complications should
be investigated, especially in those who do not improve
on ATT, who have other predisposing factors or are hospi-
talized for long periods [10]. Prophylactic anticoagulant
therapy should also be considered and the use of central
venous catheters avoided in order to prevent venous
thrombosis and its complications [3].
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